Home › NDC Lookup › RxCUI directory › RxCUI 1745062

10 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel] — RxCUI 1745062

Name: 10 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel] (RxCUI 1745062)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1745062 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1745062

Official name10 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as10 ML Exparel 13.3 MG/ML Injection; EXPAREL 1.3 % in 10 ML Injection; Exparel 133 MG per 10 ML Injection

FDA products mapped2

Package NDCs mapped4

Reported Medicaid activity (SDUD)13,447 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bupivacaine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Bupivacaine is a local anesthetic — it numbs a specific area of your body so you don't feel pain during a procedure. Your doctor or anesthesiologist injects it near the nerves that...
What exactly is bupivacaine and why is my doctor using it?
The most common ones are nausea, vomiting, constipation, dizziness, and headache. You might also notice your heart beating a little faster or your blood pressure dropping temporari...
What side effects should I expect after getting bupivacaine?

📖 Read our full Bupivacaine guide →

🕸️ Concept Web — How 10 ML bupivacaine liposome 13.3 MG/ML Injection... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 10 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel] RxCUI 1745062 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Bupivacaine 1815 IN
- Bupivacaine liposome 1191504 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Exparel 1191509 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bupivacaine Injection 1724783 SCDF
- Bupivacaine liposome Injection 2646048 SCDFP
- Bupivacaine Injectable Product 1151356 SCDG
- Bupivacaine liposome Injectable Product 2659292 SCDGP
- Bupivacaine Injection [Exparel] 2285805 SBDF
- Bupivacaine liposome Injection [Exparel] 2656165 SBDFP
- Exparel Injectable Product 1191512 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 10 ML bupivacaine liposome 13.3 MG/ML Injection 1745061 SCD
- Bupivacaine liposome 13.3 MG/ML 1191505 SCDC
- Bupivacaine liposome 13.3 MG/ML [Exparel] 1191510 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

10 ML bupivacaine liposome 13.3 MG/ML Injection SCD · 1745061
Bupivacaine liposome 13.3 MG/ML SCDC · 1191505
Bupivacaine Injection SCDF · 1724783
Bupivacaine liposome Injection SCDFP · 2646048
Bupivacaine Injectable Product SCDG · 1151356
Bupivacaine liposome Injectable Product SCDGP · 2659292

Brand-Name Concepts

Bupivacaine liposome 13.3 MG/ML [Exparel] SBDC · 1191510
Bupivacaine Injection [Exparel] SBDF · 2285805
Bupivacaine liposome Injection [Exparel] SBDFP · 2656165
Exparel Injectable Product SBDG · 1191512
Exparel BN · 1191509

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 1745062 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
65250-0133-04	4 VIAL in 1 CARTON (65250-133-04) / 10 mL in 1 VIAL (65250-...	EXPAREL	Pacira Pharmaceuticals, Inc.	2016-09-02
65250-0133-09	10 VIAL in 1 CARTON (65250-133-09) / 10 mL in 1 VIAL (65250...	EXPAREL	Pacira Pharmaceuticals, Inc.	2016-09-02
65250-0266-04	4 VIAL in 1 CARTON (65250-266-04) / 20 mL in 1 VIAL (65250-...	EXPAREL	Pacira Pharmaceuticals, Inc.	2016-09-28
65250-0266-09	10 VIAL in 1 CARTON (65250-266-09) / 20 mL in 1 VIAL (65250...	EXPAREL	Pacira Pharmaceuticals, Inc.	2017-03-31

Observed labelers: Pacira Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0666	Inj, bupivacaine liposome	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.